Clinical Trials

Currently, SOTIO Biotech is conducting a Phase 1/2 clinical trial evaluating the safety and preliminary efficacy of SOT102 in monotherapy and in combination with established standard of care therapies. The company is also conducting a first-in-human clinical trial for its CAR T cell therapy candidate, BOXR1030.

Subscribe to news